tirzepatide onset appetite suppression on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial Weight loss isn't one-size-fits-all. Both

GLP-1 medications such as semaglutide and dulaglutide have been taking the weight loss world by storm with their potential to not only suppress ones appetite for better portion control, but also to aid with overall body weight and fat loss

For example, its the number one cause of intoxication-induced seizures in some contexts

In the clinical trials of retatrutide, dose escalation was paused or reduced when participants experienced intolerable side effects, most commonly gastrointestinal symptoms such as nausea, vomiting, or diarrhoea

Key Takeaway: Mazdutide demonstrated superiority in combined glycemic control and weight loss